Jazz’s Midphase Tremor Drug Misses Mark, Future Uncertain
Jazz Pharmaceuticals hits a hurdle as its essential tremor drug trial misses primary endpoint. Awaiting Parkinson's trial results for future ...
- Latest
- Trending
Jazz Pharmaceuticals hits a hurdle as its essential tremor drug trial misses primary endpoint. Awaiting Parkinson's trial results for future ...
Crypto assets rise as Bitcoin hits $66K, VanEck Bitcoin ETF debuts on ASX, and AI-linked tokens surge 35% amid Nvidia ...
Ethereum at a crucial point as it enters a consolidation phase; traders eye potential volatility. Will ETH break out or ...
BofA raises ASM International NV's price target to €860, citing underestimated growth and strong revenue prospects as a "critical AI ...
China considers temporary anti-dumping tariffs on EU pork imports, impacting European farmers amid an ongoing trade probe into pricing practices.
Kenya braces for nationwide protests over the Finance Bill 2024; citizens express outrage over proposed tax hikes amid rising living ...
Are investors starting to see through AI hype? Some tech firms thrive, but many falter as market demands real results ...
"Ethereum rebounds to $3,527, buoyed by strong whale activity and breaking key resistance levels, but faces potential market and regulatory ...
Macquarie upgrades stock ratings for Kotak Mahindra Bank and SBI Life; downgrades Bajaj Finance and State Bank of India. Key ...
"Riot Platforms expands stock pool, updates severance terms for execs, and doubles authorized shares to 680M for future growth in ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.